Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

Clinical trial NCT06603402 · RECRUITING

Trial details

NCT number: NCT06603402
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma (ESCC)Immunotherapy

Start date: 2023-08-24
Primary completion: 2025-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.